Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (585)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
164
2025
3049
11.580
Why?
Antibodies, Monoclonal
26
2024
481
6.090
Why?
Hematopoietic Stem Cell Transplantation
28
2024
603
3.240
Why?
Antineoplastic Agents
18
2024
1222
3.180
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1031
3.170
Why?
Humans
219
2025
52483
2.230
Why?
Monoclonal Gammopathy of Undetermined Significance
11
2025
125
2.030
Why?
Thalidomide
24
2024
377
1.960
Why?
Neoplasm Recurrence, Local
15
2024
649
1.750
Why?
Immunotherapy, Adoptive
9
2024
166
1.710
Why?
Killer Cells, Natural
8
2024
116
1.690
Why?
Transplantation, Autologous
26
2024
488
1.680
Why?
Gene Expression Profiling
28
2025
1105
1.630
Why?
Interleukin-6
12
2023
278
1.610
Why?
Middle Aged
80
2025
13028
1.610
Why?
Neoplasm Proteins
13
2022
334
1.540
Why?
Hematologic Neoplasms
3
2022
106
1.520
Why?
Prognosis
48
2025
2099
1.490
Why?
Aged
80
2025
10121
1.440
Why?
Antigens, Neoplasm
6
2014
147
1.400
Why?
Clinical Trials as Topic
13
2022
467
1.380
Why?
Stem Cell Transplantation
10
2022
185
1.310
Why?
B-Cell Maturation Antigen
9
2025
98
1.290
Why?
Adult
60
2025
14161
1.250
Why?
Gene Expression Regulation, Neoplastic
20
2022
857
1.220
Why?
Combined Modality Therapy
19
2024
639
1.210
Why?
Chromosomes, Human, Pair 1
9
2023
96
1.200
Why?
Male
90
2025
26761
1.200
Why?
Female
92
2025
28171
1.180
Why?
Herpesvirus 8, Human
7
2021
98
1.170
Why?
Antibodies, Bispecific
6
2025
94
1.150
Why?
Translocation, Genetic
10
2022
265
1.140
Why?
Treatment Outcome
47
2024
5422
1.090
Why?
Boronic Acids
12
2013
183
1.070
Why?
Pyrazines
12
2013
190
1.070
Why?
Bone Marrow
18
2024
364
1.020
Why?
Proteasome Inhibitors
5
2024
104
1.010
Why?
Plasma Cells
12
2025
239
1.010
Why?
Immunotherapy
6
2024
244
0.960
Why?
Neoplasms, Second Primary
2
2024
77
0.940
Why?
Disease-Free Survival
24
2019
460
0.910
Why?
B-Lymphocytes
5
2024
184
0.880
Why?
Dexamethasone
14
2024
438
0.880
Why?
T-Lymphocytes, Cytotoxic
4
2014
66
0.860
Why?
Melphalan
9
2020
181
0.850
Why?
Cancer Vaccines
3
2010
78
0.840
Why?
Follow-Up Studies
26
2024
2279
0.820
Why?
Hyperhidrosis
1
2022
2
0.800
Why?
Sweat
1
2022
9
0.790
Why?
Survival Rate
24
2020
945
0.770
Why?
Lymphoma, B-Cell
3
2022
61
0.770
Why?
Drug Approval
1
2022
46
0.760
Why?
Positron-Emission Tomography
8
2025
301
0.730
Why?
Ehrlichia chaffeensis
1
2021
4
0.730
Why?
Patient Participation
1
2022
69
0.730
Why?
Ehrlichiosis
1
2021
14
0.720
Why?
T-Lymphocytes
8
2024
340
0.720
Why?
Cryosurgery
1
2021
36
0.720
Why?
Immunoglobulin Light Chains
3
2017
90
0.700
Why?
Disease Progression
17
2025
871
0.700
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
30
0.690
Why?
Embolization, Therapeutic
1
2021
88
0.680
Why?
Aged, 80 and over
22
2025
3392
0.680
Why?
Cell Proliferation
10
2023
1023
0.660
Why?
Neoplasm, Residual
9
2025
173
0.650
Why?
Chromosomal Instability
1
2019
16
0.640
Why?
Neoplasms, Plasma Cell
3
2024
37
0.630
Why?
Membrane Proteins
3
2006
335
0.630
Why?
Survival Analysis
18
2024
673
0.620
Why?
Adrenal Cortex Hormones
2
2023
116
0.610
Why?
Immunologic Factors
2
2018
117
0.600
Why?
Epigenesis, Genetic
4
2023
406
0.580
Why?
Tumor Microenvironment
6
2024
256
0.580
Why?
Chromosome Aberrations
12
2023
297
0.580
Why?
POEMS Syndrome
1
2018
34
0.570
Why?
Dendritic Cells
3
2014
136
0.570
Why?
Atrial Fibrillation
2
2022
200
0.560
Why?
Thyroid Neoplasms
1
2019
116
0.560
Why?
Polymorphism, Single Nucleotide
3
2024
505
0.550
Why?
Prealbumin
2
2014
22
0.550
Why?
Antibodies, Monoclonal, Humanized
6
2023
236
0.530
Why?
Receptors, Interleukin-6
2
2014
23
0.530
Why?
Cardiomyopathies
2
2014
121
0.490
Why?
Mutation
10
2022
1347
0.480
Why?
Risk Assessment
11
2025
1327
0.470
Why?
Osteolysis
4
2022
75
0.470
Why?
Immunotoxins
1
2014
6
0.450
Why?
Drug Resistance, Neoplasm
7
2024
326
0.440
Why?
Recurrence
13
2024
672
0.440
Why?
Cytotoxicity, Immunologic
2
2012
58
0.440
Why?
Risk Factors
20
2025
3889
0.440
Why?
Clonal Evolution
3
2020
58
0.430
Why?
Practice Guidelines as Topic
4
2023
488
0.430
Why?
Cyclophosphamide
5
2021
171
0.420
Why?
Health Status
1
2015
294
0.410
Why?
Amyloidosis
1
2014
85
0.410
Why?
Transplantation, Homologous
5
2017
150
0.410
Why?
Thrombocytopenia
3
2025
89
0.410
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.400
Why?
Fluorodeoxyglucose F18
6
2021
188
0.400
Why?
Remission Induction
13
2021
218
0.390
Why?
Neutropenia
2
2023
115
0.380
Why?
Genome-Wide Association Study
3
2024
186
0.380
Why?
Receptors, KIR
2
2008
12
0.380
Why?
Genetic Predisposition to Disease
3
2024
528
0.360
Why?
Bone Diseases
3
2021
96
0.360
Why?
Pyrimidines
2
2022
199
0.360
Why?
Dose-Response Relationship, Drug
8
2020
1378
0.360
Why?
Prospective Studies
9
2025
2481
0.360
Why?
Cytokines
3
2025
623
0.360
Why?
Lymph Nodes
5
2025
258
0.350
Why?
Azacitidine
1
2010
39
0.350
Why?
Benzamides
1
2010
50
0.350
Why?
Evolution, Molecular
2
2021
93
0.350
Why?
Histone Deacetylase Inhibitors
1
2010
58
0.340
Why?
C-Reactive Protein
6
2022
155
0.330
Why?
Prednisone
2
2021
102
0.330
Why?
Doxorubicin
6
2021
241
0.330
Why?
TOR Serine-Threonine Kinases
2
2020
80
0.320
Why?
Drug Administration Schedule
5
2015
374
0.320
Why?
Chromosome Deletion
5
2023
142
0.320
Why?
Metaphase
4
2016
46
0.310
Why?
Pelvis
2
2021
69
0.310
Why?
Quality of Life
1
2015
879
0.310
Why?
Vaccination
4
2022
298
0.310
Why?
Membrane Glycoproteins
2
2009
244
0.300
Why?
Paraproteinemias
3
2022
74
0.300
Why?
Disease Management
3
2025
188
0.300
Why?
Animals
15
2024
13505
0.290
Why?
Proportional Hazards Models
7
2024
443
0.290
Why?
Placebo Effect
2
2020
16
0.290
Why?
Fever
3
2025
112
0.290
Why?
Bone Neoplasms
4
2013
184
0.290
Why?
Young Adult
8
2025
4329
0.290
Why?
Adoptive Transfer
1
2007
29
0.290
Why?
Histocompatibility Antigens Class I
1
2007
48
0.280
Why?
Chromatin
3
2023
139
0.280
Why?
CD8-Positive T-Lymphocytes
3
2024
132
0.280
Why?
Cytogenetic Analysis
5
2023
80
0.280
Why?
Registries
4
2025
581
0.270
Why?
Boron Compounds
2
2024
19
0.270
Why?
DNA Methylation
4
2023
592
0.270
Why?
Chromans
2
2024
35
0.270
Why?
Vincristine
3
2021
88
0.260
Why?
Cell Membrane
1
2007
245
0.260
Why?
Mice, SCID
6
2013
182
0.260
Why?
Glycine
2
2024
75
0.260
Why?
Angiogenesis Inhibitors
5
2010
183
0.260
Why?
Down-Regulation
1
2007
346
0.260
Why?
In Situ Hybridization, Fluorescence
5
2023
263
0.250
Why?
Neoplasm Staging
6
2024
772
0.250
Why?
Consensus
3
2025
181
0.250
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Cell Line, Tumor
9
2023
1470
0.240
Why?
Vitamin E
2
2024
77
0.240
Why?
Transplantation Conditioning
5
2008
93
0.240
Why?
Case-Control Studies
6
2024
1201
0.240
Why?
Bone Resorption
2
2022
302
0.240
Why?
Mice
11
2024
5949
0.240
Why?
Infusions, Intravenous
3
2015
220
0.240
Why?
Connective Tissue Diseases
1
2025
20
0.240
Why?
Antibody Formation
1
2005
51
0.230
Why?
Immunoglobulins, Intravenous
1
2025
63
0.230
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
Time Factors
11
2021
2968
0.220
Why?
Autoantibodies
1
2025
121
0.220
Why?
Flow Cytometry
4
2012
478
0.220
Why?
Monocytes
2
2020
130
0.220
Why?
Gene Expression
2
2018
618
0.220
Why?
High-Throughput Nucleotide Sequencing
3
2022
182
0.210
Why?
Cell Cycle Proteins
2
2022
169
0.210
Why?
Ubiquitin-Protein Ligases
1
2024
96
0.210
Why?
Blotting, Western
3
2015
590
0.210
Why?
Proteasome Endopeptidase Complex
3
2011
117
0.210
Why?
Epstein-Barr Virus Infections
2
2020
32
0.210
Why?
Signal Transduction
6
2021
1671
0.210
Why?
Radiation-Protective Agents
1
2024
72
0.210
Why?
Integrin beta Chains
1
2023
14
0.210
Why?
Integrins
1
2023
31
0.200
Why?
Retrospective Studies
11
2025
6607
0.200
Why?
Double-Blind Method
2
2015
713
0.200
Why?
Cross-Sectional Studies
3
2023
1678
0.200
Why?
Sweating
1
2022
13
0.200
Why?
Hematopoietic Stem Cells
2
2022
187
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
81
0.190
Why?
DNA, Intergenic
1
2022
6
0.190
Why?
Tumor Cells, Cultured
4
2013
460
0.190
Why?
Kaplan-Meier Estimate
10
2016
483
0.190
Why?
Proteomics
3
2021
329
0.190
Why?
Immunoconjugates
1
2022
39
0.190
Why?
Receptors, Antigen, T-Cell
1
2022
54
0.190
Why?
Tumor Suppressor Protein p53
2
2017
221
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
United States Food and Drug Administration
1
2022
98
0.190
Why?
United States
4
2022
5192
0.190
Why?
Influenza, Human
1
2022
93
0.180
Why?
Mediastinum
1
2021
21
0.180
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Receptors, Glucocorticoid
2
2012
34
0.180
Why?
Apoptosis
5
2018
1119
0.180
Why?
Ubiquitination
1
2021
47
0.180
Why?
Axilla
1
2021
92
0.180
Why?
Phosphatidylinositol 3-Kinases
2
2019
151
0.180
Why?
Multiple Organ Failure
1
2021
49
0.180
Why?
Alleles
3
2021
276
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
91
0.180
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.180
Why?
Salvage Therapy
6
2013
136
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.170
Why?
Rare Diseases
1
2020
47
0.170
Why?
Adolescent
7
2025
6739
0.170
Why?
Interferon-gamma
3
2014
180
0.170
Why?
Transcriptome
5
2025
370
0.170
Why?
Genes, Tumor Suppressor
2
2021
74
0.170
Why?
Radiopharmaceuticals
4
2021
204
0.170
Why?
Cell Cycle
1
2021
230
0.170
Why?
Longitudinal Studies
5
2024
747
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Interferon Type I
1
2020
27
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Myelodysplastic Syndromes
2
2013
86
0.170
Why?
Research Design
2
2020
359
0.160
Why?
Multivariate Analysis
8
2021
591
0.160
Why?
ROC Curve
2
2025
253
0.160
Why?
Genomics
4
2023
268
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
Measles virus
1
2019
8
0.160
Why?
Measles
1
2019
8
0.160
Why?
DNA
1
2023
549
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Data Collection
1
2020
290
0.160
Why?
Immunohistochemistry
2
2015
979
0.160
Why?
Oncolytic Virotherapy
1
2019
21
0.160
Why?
Health Status Disparities
1
2022
215
0.160
Why?
Biopsy
5
2018
605
0.160
Why?
Patient Safety
1
2020
104
0.160
Why?
Sirolimus
1
2019
65
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
Cell Differentiation
6
2022
665
0.150
Why?
Precancerous Conditions
2
2010
85
0.150
Why?
Evidence-Based Medicine
2
2018
261
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
169
0.150
Why?
Syndrome
1
2019
247
0.150
Why?
Healthcare Disparities
1
2022
299
0.150
Why?
MafB Transcription Factor
1
2018
9
0.150
Why?
Graft vs Host Disease
4
2007
87
0.150
Why?
Spleen
1
2019
172
0.150
Why?
Genomic Instability
2
2016
89
0.150
Why?
Phosphotransferases
1
2018
17
0.150
Why?
Immunomodulation
1
2018
38
0.150
Why?
Chemokines
1
2018
79
0.140
Why?
Plasma
1
2018
45
0.140
Why?
Myeloablative Agonists
2
2008
32
0.140
Why?
Hematopoietic Stem Cell Mobilization
2
2008
60
0.140
Why?
Osteoclasts
3
2022
428
0.140
Why?
Genes, Neoplasm
2
2015
31
0.140
Why?
Adipocytes
1
2018
132
0.140
Why?
Models, Biological
2
2018
735
0.140
Why?
Magnetic Resonance Imaging
5
2013
1546
0.140
Why?
Gene Dosage
2
2015
78
0.140
Why?
Gene Rearrangement
1
2018
75
0.140
Why?
Hexokinase
1
2017
16
0.140
Why?
Communication
1
2019
257
0.140
Why?
Heterozygote
2
2014
90
0.140
Why?
Protein-Tyrosine Kinases
2
2018
87
0.130
Why?
HLA-A Antigens
2
2007
11
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Drug Therapy, Combination
1
2018
395
0.130
Why?
Oligonucleotide Array Sequence Analysis
5
2010
405
0.130
Why?
Gene Frequency
2
2013
98
0.130
Why?
Syndecan-1
4
2021
74
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.120
Why?
Lymphocyte Activation
2
2017
172
0.120
Why?
Critical Illness
1
2018
317
0.120
Why?
Tumor Burden
3
2020
136
0.120
Why?
Confidence Intervals
2
2014
158
0.120
Why?
Erythrocyte Indices
1
2015
7
0.120
Why?
Biomarkers, Pharmacological
2
2012
26
0.120
Why?
Immunity, Innate
1
2016
117
0.120
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Coculture Techniques
2
2013
144
0.120
Why?
Hemoglobins
2
2013
112
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
88
0.110
Why?
International Cooperation
1
2014
49
0.110
Why?
Fatigue
1
2015
125
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
235
0.110
Why?
Iron
1
2015
127
0.110
Why?
Area Under Curve
1
2014
180
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Antibodies
2
2024
159
0.110
Why?
Reference Values
1
2014
313
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
77
0.110
Why?
Emotions
1
2015
174
0.110
Why?
Renal Insufficiency
2
2021
113
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Severity of Illness Index
2
2014
1026
0.110
Why?
Disease Models, Animal
2
2016
1478
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Inflammation Mediators
1
2014
115
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Cisplatin
4
2013
285
0.100
Why?
Macaca mulatta
2
2024
92
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
Central Nervous System Neoplasms
1
2013
68
0.100
Why?
beta Catenin
1
2013
102
0.100
Why?
Oligopeptides
1
2013
92
0.100
Why?
Venous Thrombosis
2
2004
90
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Edema
2
2025
66
0.100
Why?
Cell Survival
2
2020
612
0.100
Why?
Pain
1
2015
362
0.100
Why?
Mental Health
1
2015
240
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
77
0.100
Why?
Maintenance Chemotherapy
1
2012
51
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
182
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
202
0.100
Why?
Models, Genetic
2
2016
169
0.100
Why?
Interleukin-2
1
2012
69
0.100
Why?
Mice, Inbred NOD
1
2012
92
0.090
Why?
Immunoenzyme Techniques
1
2012
137
0.090
Why?
Cell Movement
1
2013
268
0.090
Why?
Hemangioma
1
2013
84
0.090
Why?
Soft Tissue Neoplasms
1
2012
57
0.090
Why?
Immunoglobulin G
2
2025
195
0.090
Why?
Genotype
1
2013
566
0.090
Why?
Arkansas
5
2021
2028
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
44
0.090
Why?
Chemokine CXCL13
2
2022
6
0.090
Why?
Models, Statistical
2
2014
230
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
59
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
Hypersensitivity, Delayed
1
2010
18
0.090
Why?
CD40 Ligand
1
2010
15
0.090
Why?
Interleukin-4
1
2010
44
0.090
Why?
Secondary Prevention
1
2010
84
0.090
Why?
Up-Regulation
4
2018
454
0.090
Why?
HIV Seropositivity
1
2010
28
0.080
Why?
Eukaryotic Initiation Factor-2
1
2010
17
0.080
Why?
Immunity, Cellular
1
2010
64
0.080
Why?
Adjuvants, Immunologic
1
2010
52
0.080
Why?
Cell Line
2
2013
1030
0.080
Why?
Cells, Cultured
3
2013
1567
0.080
Why?
Etoposide
2
2007
74
0.080
Why?
Ovarian Neoplasms
1
2014
459
0.080
Why?
Transplantation, Heterologous
1
2009
79
0.080
Why?
Placenta
1
2011
153
0.080
Why?
Radiography
4
2012
470
0.080
Why?
Polymerase Chain Reaction
1
2010
461
0.080
Why?
Histones
2
2021
314
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.080
Why?
Hospitalization
2
2024
736
0.080
Why?
Transcription Factors
2
2023
566
0.080
Why?
Liver Neoplasms
1
2012
333
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.070
Why?
Haplotypes
1
2008
92
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
64
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Bone and Bones
3
2021
494
0.070
Why?
Gene Deletion
1
2009
272
0.070
Why?
Neoplastic Stem Cells
1
2009
99
0.070
Why?
Ligands
1
2008
206
0.070
Why?
Receptors, Immunologic
1
2008
39
0.070
Why?
Osteogenesis
1
2011
366
0.070
Why?
Twins
1
2007
33
0.070
Why?
Busulfan
1
2007
17
0.070
Why?
Diphosphonates
1
2008
92
0.070
Why?
Herpesviridae Infections
2
2019
57
0.070
Why?
Immunophenotyping
1
2007
117
0.070
Why?
Leukocytes, Mononuclear
1
2007
123
0.070
Why?
Caspases
2
2018
104
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Creatinine
1
2007
150
0.070
Why?
Skin Neoplasms
1
2012
505
0.070
Why?
Blood Proteins
1
2007
85
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.060
Why?
Immunosuppressive Agents
1
2008
243
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Plasmacytoma
1
2006
43
0.060
Why?
Cohort Studies
3
2020
1542
0.060
Why?
Amiloride
1
2005
7
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Bone Marrow Transplantation
2
2022
113
0.060
Why?
MicroRNAs
1
2010
387
0.060
Why?
Imaging, Three-Dimensional
2
2017
154
0.060
Why?
Decision Trees
1
2025
22
0.060
Why?
Sensitivity and Specificity
1
2007
891
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
29
0.060
Why?
Japan
1
2025
38
0.060
Why?
Predictive Value of Tests
3
2018
944
0.060
Why?
Tomography, X-Ray Computed
2
2023
1165
0.060
Why?
Child
3
2025
7248
0.060
Why?
Autoantigens
1
2025
53
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
3
0.060
Why?
Piperidones
1
2024
7
0.060
Why?
Enoxaparin
1
2004
31
0.060
Why?
Telomere
1
2024
38
0.060
Why?
Retreatment
1
2024
58
0.060
Why?
NF-kappa B
2
2018
322
0.050
Why?
Morpholines
1
2024
66
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Cost of Illness
1
2024
121
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
56
0.050
Why?
Epidemiologic Methods
3
2008
46
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Gene Silencing
2
2016
118
0.050
Why?
Neoplasms
1
2014
1325
0.050
Why?
Fibroblasts
1
2005
355
0.050
Why?
Cluster Analysis
3
2010
233
0.050
Why?
Cell Communication
1
2023
71
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Whole-Body Irradiation
1
2022
127
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
17
0.050
Why?
Phenotype
1
2025
789
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Primary Cell Culture
1
2022
62
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
Quantitative Trait Loci
1
2022
50
0.050
Why?
Risk
2
2014
316
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Phylogeny
1
2022
231
0.050
Why?
Anticoagulants
1
2004
270
0.050
Why?
Age of Onset
2
2013
110
0.050
Why?
RANK Ligand
1
2022
187
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Rabbits
2
2013
375
0.040
Why?
Child, Preschool
2
2020
4076
0.040
Why?
Polymorphism, Genetic
1
2022
185
0.040
Why?
Transcriptional Activation
1
2021
122
0.040
Why?
Base Sequence
1
2022
640
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Fibrosis
1
2021
196
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Repressor Proteins
1
2022
155
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Protein Kinase Inhibitors
1
2022
227
0.040
Why?
Genetic Loci
1
2020
49
0.040
Why?
Mice, Transgenic
1
2021
552
0.040
Why?
Single-Cell Analysis
1
2020
81
0.040
Why?
False Negative Reactions
1
2019
30
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Neoplasm Invasiveness
1
2020
278
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Incidence
2
2013
1062
0.040
Why?
Europe
1
2019
87
0.040
Why?
Herpesvirus 4, Human
1
2019
43
0.040
Why?
Communicable Disease Control
1
2019
38
0.040
Why?
Computational Biology
1
2020
212
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
Genome, Viral
1
2019
83
0.040
Why?
DNA, Viral
1
2019
137
0.040
Why?
RNA, Messenger
2
2016
1132
0.040
Why?
Virus Diseases
1
2019
46
0.040
Why?
Fibrinogen
1
2018
34
0.040
Why?
Immunoglobulin A
1
2018
45
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
Platelet Count
2
2008
75
0.040
Why?
DNA-Binding Proteins
1
2021
422
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Pathology, Molecular
1
2018
28
0.040
Why?
Oncogene Proteins, Fusion
1
2018
61
0.040
Why?
Data Interpretation, Statistical
2
2010
164
0.040
Why?
Databases, Factual
2
2013
706
0.040
Why?
Kidney Function Tests
1
2017
54
0.030
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Glomerular Filtration Rate
1
2017
124
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
184
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Internationality
1
2017
43
0.030
Why?
Amino Acid Sequence
1
2018
578
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
78
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Proteolysis
1
2016
101
0.030
Why?
Enzyme Activation
1
2016
270
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Chromosome Mapping
2
2006
154
0.030
Why?
Prevalence
1
2019
1006
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
107
0.030
Why?
Phosphorylation
1
2016
528
0.030
Why?
Kidney Diseases
1
2017
220
0.030
Why?
Myocardium
1
2017
453
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Karyotype
1
2014
19
0.030
Why?
Capsid
1
2014
2
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
59
0.030
Why?
Homozygote
1
2013
59
0.030
Why?
Cerebrospinal Fluid
1
2013
31
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Diagnosis, Differential
1
2017
1046
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Acrylamides
1
2013
8
0.030
Why?
Receptors, CXCR4
1
2013
29
0.030
Why?
Dependovirus
1
2014
103
0.030
Why?
Niacinamide
1
2013
23
0.030
Why?
Enzyme Induction
1
2013
77
0.030
Why?
NAD
1
2013
45
0.030
Why?
Amides
1
2013
37
0.030
Why?
Nitriles
1
2013
53
0.030
Why?
Sirtuin 1
1
2013
29
0.030
Why?
Chemokine CXCL12
1
2013
32
0.030
Why?
Gene Knockdown Techniques
1
2013
108
0.030
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
RNA, Small Interfering
1
2013
213
0.020
Why?
Piperidines
1
2013
97
0.020
Why?
Infant
1
2020
3733
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Acute Disease
1
2013
373
0.020
Why?
Induction Chemotherapy
1
2012
64
0.020
Why?
Chemokine CXCL10
1
2011
20
0.020
Why?
HIV Infections
1
2016
389
0.020
Why?
Antibodies, Neutralizing
1
2011
78
0.020
Why?
Sex Factors
1
2013
727
0.020
Why?
Pharmacogenetics
1
2011
50
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
25
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
47
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
48
0.020
Why?
Enzyme Inhibitors
1
2013
372
0.020
Why?
Microarray Analysis
1
2010
71
0.020
Why?
International Classification of Diseases
1
2010
67
0.020
Why?
Argonaute Proteins
1
2010
12
0.020
Why?
RNA-Binding Proteins
1
2011
128
0.020
Why?
Oligonucleotides
1
2010
76
0.020
Why?
Polyploidy
1
2009
9
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
71
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Neoplasm Metastasis
1
2009
243
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Polyethylene Glycols
1
2008
90
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
220
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
595
0.020
Why?
Age Distribution
1
2007
174
0.020
Why?
Recombinant Proteins
1
2008
483
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
53
0.020
Why?
Multigene Family
1
2006
48
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
87
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
203
0.020
Why?
Brain
1
2013
1323
0.020
Why?
Survivors
1
2006
120
0.010
Why?
Pregnancy
1
2011
2680
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
172
0.010
Why?
Administration, Oral
1
2003
451
0.010
Why?
Tissue Donors
1
2003
126
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description